Tag

Pregnancy Safety

All articles tagged with #pregnancy safety

health1 day ago•60 min saved

Salmon, reimagined: experts rate the healthiest ways to enjoy the pink fish

The piece evaluates how different salmon preparations—raw (sushi/sashimi/poké), poached, smoked, baked, grilled, as well as dishes like fish pie, salmon burgers, en croûte, and tinned salmon—affect fat, calories and omega-3 content, noting skin-on can boost nutrients and moisture. It discusses safety considerations (parasite risks with raw fish and high salt in smoked salmon), pregnancy and NHS guidelines on weekly oily-fish portions, and highlights how pairing salmon with fiber-rich carbs and veggies can boost nutrient absorption and overall health.

via Daily Mail|

#cooking-methods #health #nutrition

law-and-health3 months ago•3 min saved

Texas Seeks Court Action Against Tylenol Advertising and Dividend

Texas Attorney General Ken Paxton has requested a federal judge to issue a restraining order against Tylenol's makers, Johnson & Johnson and Kenvue, to stop them from advertising the drug as safe for pregnant women and children, amid claims of deceptive marketing and conflicting health guidance from the FDA and presidential warnings.

via abcnews.go.com|

#advertising #law-and-health #pregnancy-safety

health5 months ago•3 min saved

Unveiling the Hidden Mechanisms of Tylenol's Safety and Effectiveness

Tylenol (acetaminophen) is a widely used and generally safe over-the-counter medication for pain and fever, working primarily on the central nervous system without anti-inflammatory effects. Despite recent unfounded claims linking Tylenol to autism, reputable health organizations affirm its safety during pregnancy and clarify that vaccines and medication do not cause autism. Proper dosage and medical guidance are essential for safe use.

via USA Today|

#acetaminophen #autism #health

health6 months ago•5 min saved

Gender Disparities in MS Treatment and Pregnancy-Related Risks

A French study found women with relapsing-remitting MS aged 18-40 are significantly less likely than men to receive disease-modifying therapies, despite evidence supporting their safety during pregnancy. The gap persists even after accounting for pregnancy-related treatment discontinuation, highlighting the need for better education on treatment guidelines to prevent long-term disability in women.

via Multiple Sclerosis News Today|

#dmts #gender-gap #health